These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34620614)

  • 1. Predicting the impact of control strategies on the tuberculosis burden in South and North Korea using a mathematical model.
    Cho H; Park Y; Seok J; Yeom JS; Choi JY; Kim HJ; Kang YA; Lee J
    BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34620614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Disability-Adjusted Life Years (DALYs) and Economic Burden on People With Drug-Susceptible Tuberculosis and Multidrug-Resistant Tuberculosis in Korea.
    Lee S; Kim MJ; Lee SH; Kim HY; Kim HS; Oh IH
    Front Public Health; 2022; 10():848370. PubMed ID: 35480575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Drug Resistant Tuberculosis in Sanatoria of North Korea.
    Jung J; Jegal Y; Ki M; Shin YJ; Kim CT; Shim TS; Sung N
    J Korean Med Sci; 2017 Jul; 32(7):1105-1110. PubMed ID: 28581266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?
    Seung KJ; Franke M; Linton SW
    PLoS Med; 2016 Aug; 13(8):e1002062. PubMed ID: 27483430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of tuberculosis burden in China using a dynamic disease simulation model.
    Mehra M; Cossrow N; Kambili C; Underwood R; Makkar R; Potluri R
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1186-94. PubMed ID: 23827732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling drug-resistant tuberculosis amplification rates and intervention strategies in Bangladesh.
    Kuddus MA; Meehan MT; White LJ; McBryde ES; Adekunle AI
    PLoS One; 2020; 15(7):e0236112. PubMed ID: 32702052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis in North Korea.
    Perry S; Linton H; Schoolnik G
    Science; 2011 Jan; 331(6015):263. PubMed ID: 21252318
    [No Abstract]   [Full Text] [Related]  

  • 9. Scenario analysis for programmatic tuberculosis control in Bangladesh: a mathematical modelling study.
    Kuddus MA; Meehan MT; Sayem MA; McBryde ES
    Sci Rep; 2021 Feb; 11(1):4354. PubMed ID: 33623132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019.
    Lee T; Lee SJ; Jeon D; Lee HY; Kim HJ; Kang BH; Mok J
    J Korean Med Sci; 2021 Jul; 36(26):e174. PubMed ID: 34227261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public enemy number one.
    Stone R
    Science; 2013 Apr; 340(6131):422-5. PubMed ID: 23620029
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost of treatment for multidrug-resistant tuberculosis in South Korea.
    Kang YA; Choi YJ; Cho YJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Respirology; 2006 Nov; 11(6):793-8. PubMed ID: 17052310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
    Cox HS; McDermid C; Azevedo V; Muller O; Coetzee D; Simpson J; Barnard M; Coetzee G; van Cutsem G; Goemaere E
    PLoS One; 2010 Nov; 5(11):e13901. PubMed ID: 21085569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Cost-Exemption Policy on Treatment Interruption in Patients With Newly Diagnosed Pulmonary Tuberculosis in South Korea.
    Lee SC; Lee JK; Ji HW; Lee JM; Park SC; Han CH
    Int J Health Policy Manag; 2024; 13():8262. PubMed ID: 39099483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
    Laurence YV; Griffiths UK; Vassall A
    Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
    Nourzad S; Jenkins HE; Milstein M; Mitnick CD
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):6-11. PubMed ID: 28157458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achievements in and Challenges of Tuberculosis Control in South Korea.
    Kim JH; Yim JJ
    Emerg Infect Dis; 2015 Nov; 21(11):1913-20. PubMed ID: 26485188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating tuberculosis drug resistance amplification rates in high-burden settings.
    Karmakar M; Ragonnet R; Ascher DB; Trauer JM; Denholm JT
    BMC Infect Dis; 2022 Jan; 22(1):82. PubMed ID: 35073862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003.
    Feja K; McNelley E; Tran CS; Burzynski J; Saiman L
    Pediatr Infect Dis J; 2008 Oct; 27(10):907-12. PubMed ID: 18756183
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.